SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john dixon who wrote (839)12/10/1997 1:48:00 PM
From: Tim K  Read Replies (2) of 3702
 
To all: This note appeared yesterday in a daily newsletter my employer publishes on our intranet. Anyone have yesterday's NYT and can check it out?

Dr. Judah Folkman's 35-year-old theory that tumors must somehow induce the body to build the blood vessels that feed them is finally
achieving widespread acceptance. More than 100 laboratories and as many as 40 biotechnology companies are seeking to identify the
chemical signals the body uses to construct and dismantle a temporary new blood supply in events like wound-healing, menstruation and
cancer. (NYT, F1)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext